Sarvari Yellapragada, MD, Oncology, Houston, TX, Michael E. DeBakey Veterans Affairs Medical Center

SarvariVenkataYellapragadaMD

Oncology Houston, TX

Hematologic Oncology

Assistant Professor, Hematology & Oncology, Baylor College of Medicine

Dr. Yellapragada is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Yellapragada's full profile

Already have an account?

  • Office

    2002 Holcombe Blvd
    Department Of Hematology Oncology
    Houston, TX 77030
    Phone(713) 791-1414
    Fax(713) 794-7733
  • Is this information wrong?

Education & Training

  • Baylor College of Medicine
    Baylor College of MedicineFELLOWSHIP
  • Mount Sinai St. Luke's - West Hospital Center
    Mount Sinai St. Luke's - West Hospital CenterRESIDENCY
  • Madras Medical College
    Madras Medical CollegeMEDICAL_SCHOOL

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 2007 - 2021
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • With Equal Access, African Americans with Non-del17p Multiple Myeloma Have Superior Overall Survival, but del17p Still Carries Poor Prognosis across Race: A VA Study
    Sarvari Venkata Yellapragada, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Differential Induction Among Younger Patients Diagnosed with Secondary Acute Myelogenous Leukemia Is Feasible By Cytogenetic/Molecular Risk Stratification
    Sarvari Venkata Yellapragada, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Incidence of Second Primary Malignancies and Association with Treatment in US Veterans with Multiple Myeloma
    Sarvari Venkata Yellapragada, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

  • Predictive Factors for Complete Remission and Survival in AML Patients Failing to Achieve Adequate Bone Marrow Day 14 Blast Eradication 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Vitamin D Deficiency Predicts for Poor Overall Survival in Caucasian but Not African American Patients with Multiple Myeloma 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Hospital Affiliations